Mass General Brigham Incorporated
Location
Massachusetts
Founded
1994-02-13
Risk Signals
1496 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., General Medical and Surgical Hospitals), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Mass General Brigham Incorporated
Live alerts from global media, monitored by Business Radar
2024-10-10 (etfdailynews.com)
SG Americas Securities LLC Purchases 20,724 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
SG Americas Securities LLC increased its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 193.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Read more2024-09-20 (cision.com)
Nightingale Health Plc Financial Statements Release 1 July 2023 – 30 June 2024
Nightingale Health Plc Company release 20 September 2024 at 9:00 a.m. (EEST)
Read more2024-09-05 (list23.com)
Despite a promising pain medication of the next generation, chronic sufferers require more alternatives
<p>During her mid-20s, Megan Hodge, her mother, and husband were preparing to go to see family for Thanksgiving, which marked the first time she experienced such excruciating pain. Despite having a va ...
Read more2024-07-09 (etnews.com)
[Scale Up Tips Global Forum] U.S. FDA approval strategy for medical AI companies
Domestic medical artificial intelligence (AI) companies are actively preparing for overseas expansion through US FDA approval. This is a strategic choice to overcome regulations and limited profit models in the domestic medical market and enter the US market, the world's largest. To this end, domestic companies rely on excellent human resources.
Read more2023-11-14 (ormanager.com)
Rules and Regulations Archives - OR Manager
News and Information for Today's Surgical Suite Leaders
Read more2023-10-03 (marketbeat.com)
Mass General Brigham Inc Invests $10.48 Million in Samsara Inc. (NYSE:IOT)
Mass General Brigham Inc acquired a new stake in Samsara Inc. (NYSE:IOT - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 378,035 shares of the company's stock, valued at approximately $10,475,000
Read more2022-11-28 (nature.com)
Novice-performed point-of-care ultrasound for home-based imaging | Scientific Reports
Scientific Reports - Novice-performed point-of-care ultrasound for home-based imaging
Read more2022-10-25 (nature.com)
Predicting radiocephalic arteriovenous fistula success with machine learning | npj Digital Medicine
npj Digital Medicine - Predicting radiocephalic arteriovenous fistula success with machine learning
Read more2022-05-05 (fiercehealthcare.com)
Mass General Brigham receives state approval for $2B in hospital expansions
Updated on May 5, 11:30 a.m.Mass General Brigham (MGB) has received state regulatory approval for a trimmed down, $2 billion-plus expansion for two of its major hospitals. | The conditional, trimmed down plan includes$ 150 million for Brigham and Women 's Faulkner Hospital and$ 1.9 billion for
Read more2022-05-05 (commonwealthmagazine.org)
Wu calls MGH project a ‘catalytic investment’ - CommonWealth Magazine
BOSTON MAYOR Michelle Wu is calling the construction of two connected towers at Massachusetts General Hospital a “catalytic investment” that could not only boost health care in the city but transform public transportation.
Read more2022-02-28 (commonwealthmagazine.org)
DPH has final say on expansions, but will it use it? - CommonWealth Magazine
AFTER RECEIVING input from the attorney general’ s office and Health Policy Commission, the Department of Public Health is considering whether to approve or reject a proposal by Mass General Brigham to build ambulatory care centers in Woburn,
Read more2022-02-17 (khn.org)
KHN’s ‘What the Health?’: It’s Health Costs, Stupid (2022 Edition)
As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissione…
Read more